Annual Securities Report — FY2025
What COSMOS Pharmaceutical Corporation reported for the period from 2025-06-01 to 2026-05-31. Filed by 株式会社コスモス薬品
Filed 2026-08-26View the original on EDINET
How much it says
49Typical
What moved here
8named for the first time
Its own wording
46terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the current consolidated fiscal year, the company opened 105 new stores and closed 6 through active store openings and scrap-and-build initiatives, bringing the fiscal year-end store count to 1,708. Revenue was ¥1,099,583 million, while profit attributable to owners of the parent was ¥32,046 million.
Komori's summary of this document, not the document's own words.49Typical
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 36 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
64
Detailed
45
Typical
54
Typical
38
Thin
0
Almost nothing
50
Typical
68
Detailed
27
Almost nothing
100
Very detailed
7
Almost nothing
55
Typical
73
Detailed
R&D spend0百万円Money spent making new things.
Cash left over-231億円Cash from the business, less what went into equipment.
Spent on equipment768億円Plants, machines — things meant to last.
Employees5,977Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.